![Memorial Sloan Kettering Pathologist Kseniya Petrova-Drus](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/node/241558/3x2/petrova-drus-kseniya_170925_04-1200x800.jpg?h=10d202d3)
Kseniya Petrova-Drus, MD, PhD
Pathologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Hematopathology
- Molecular Genetic Pathology
- Anatomic and Clinical Pathology
Request an Appointment
About Me
- Assistant Attending Pathologist
I am a pathologist specializing in hematopathology and molecular genetic pathology. In my primary clinical work, I provide diagnoses for patients with hematological malignancies, which include chronic myeloid conditions, leukemias, lymphomas, and myelomas, among others. Then, a clinical oncologist is able to choose the most appropriate therapy for the patient’s disease. This involves direct examination of the blood, bone marrow, lymph nodes, and other tissues, while integrating information on various tumor cell characteristics, including their genetic features.
Read more
As part of the cutting-edge Diagnostic Molecular Pathology Laboratory at Memorial Sloan Kettering Cancer Center, I also work as a molecular genetic pathologist with a focus on detecting genetic changes in malignant tissues. The information that we can get from observing these changes helps to confirm or clarify the cancer type, tailor personalized treatment, determine the disease prognosis and risk of recurrence, and guide disease monitoring once therapy has started. Having expertise in both fields of hematopathology and molecular genetic pathology allows me to easily integrate this information to help elucidate the diagnosis, as well as be familiar with any pitfalls in the methodologies used in these two specialties.
My research efforts are focused on further characterizing rare diseases, such as a rare leukemia harboring a unique genetic aberration. In addition, I am involved in efforts to apply the most advanced molecular techniques to detect well-established features of B-cell malignancies, such as chronic lymphocytic leukemia. I try to gain additional prognostic information from these new approaches.
I also look at other ways to apply cutting-edge molecular strategies for analyzing cancer tissue. I hope to improve our understanding of hematological malignancies, how they arise, how to accurately diagnose them, and ultimately, how to best treat them. As a physician-scientist, both hematopathology and molecular genetic pathology were especially fascinating fields for me because they rapidly translate advanced scientific discoveries into clinical applications.
A pathologist is a doctor who uses a microscope to make a diagnosis from cell and tissue samples. They analyze the samples to learn the cause and effects of a health condition.
My Specialties
- Hematopathology
- Molecular Genetic Pathology
- Anatomic and Clinical Pathology
Education
- MD/PhD, New York University School of Medicine
Residencies
- Anatomic and Clinical Pathology - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Awards and Honors
- Young Investigator Poster Award, AMP Global Congress (2017)
Fellowships
- Hematopathology - NewYork-Presbyterian Hospital/Weill Cornell Medical Center
Board Certifications
- Hematopathology
- Molecular Genetic Pathology
- Anatomic and Clinical Pathology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
![Women talking](https://www.mskcc.org/sites/default/files/styles/width_600_1x1/public/paragraph/132166/cta_image/app-220128-006_rt_1200x800.jpeg?h=10d202d3)
Request an Opinion
Current Patients
Contact and Location
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all Hematopathology doctors
See all Molecular Diagnostics doctors
Clinical Trials
![Smiling doctors in the lab](/themes/mskcc/images/clinicaltrials_small.png)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Kseniya Petrova-Drus discloses the following relationships and financial interests:
-
Invivoscribe
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].